Connecticut HB 6062: AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS.

Status: REF. BY HOUSE TO COMMITTEE ON Appropriations (as of 2025-04-29)

State: Connecticut · Session: 2025 · Bill: HB 6062

Subjects: Advertising, Consumer Protection Department, Consumer protection, Drugs, Pharmaceutical manufacturing companies, Unfair or deceptive trade practices, Violations

View Connecticut HB 6062 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.